Managing neurocysticercosis: challenges and solutions

Yannick Fogoum Fogang, Abdoul Aziz Savadogo, Massaman Camara, Dènahin Hinnoutondji Toffa, Anna Basse, Adjaratou Djeynabou Sow, Mouhamadou Mansour Ndiaye Neurology Department, Fann Teaching Hospital, Cheikh Anta Diop University, Dakar, Senegal Abstract: Taenia solium neurocysticercosis (N...

Full description

Bibliographic Details
Main Authors: Fogang YF, Savadogo AA, Camara M, Toffa DH, Basse A, Sow AD, Ndiaye MM
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:International Journal of General Medicine
Online Access:https://www.dovepress.com/managing-neurocysticercosis-challenges-and-solutions-peer-reviewed-article-IJGM
_version_ 1817994169680920576
author Fogang YF
Savadogo AA
Camara M
Toffa DH
Basse A
Sow AD
Ndiaye MM
author_facet Fogang YF
Savadogo AA
Camara M
Toffa DH
Basse A
Sow AD
Ndiaye MM
author_sort Fogang YF
collection DOAJ
description Yannick Fogoum Fogang, Abdoul Aziz Savadogo, Massaman Camara, Dènahin Hinnoutondji Toffa, Anna Basse, Adjaratou Djeynabou Sow, Mouhamadou Mansour Ndiaye Neurology Department, Fann Teaching Hospital, Cheikh Anta Diop University, Dakar, Senegal Abstract: Taenia solium neurocysticercosis (NCC) is a major cause of neurological morbidity in the world. Variability in the neuropathology and clinical presentation of NCC often make it difficult to diagnose and manage. Diagnosis of NCC can be challenging especially in endemic and resource-limited countries where laboratory and imaging techniques are often lacking. NCC management can also be challenging as current treatment options are limited and involve symptomatic agents, antiparasitic agents, or surgery. Although antiparasitic treatment probably reduces the number of active lesions and long-term seizure frequency, its efficacy is limited and strategies to improve treatment regimens are warranted. Treatment decisions should be individualized in relation to the type of NCC. Initial measures should focus on symptomatic management, with antiparasitic therapy only to be considered later on, when appropriate. Symptomatic treatment remains the cornerstone in NCC management which should not only focuses on epilepsy, but also on other manifestations that cause considerable burden (recurrent headaches, cognitive decline). Accurate patients' categorization, better antiparasitic regimens, and definition of new clinical outcomes for trials on NCC could improve management quality and prognosis of NCC. Prevention strategies targeting tapeworm carriers and infected pigs are yielding good results in local models. If local elimination of transmission is confirmed and replicated, this will open the door to cysticercosis eradication efforts worldwide. Keywords: neurocysticercosis, Taenia solium, epilepsy, headache, albendazole, praziquantel
first_indexed 2024-04-14T01:48:22Z
format Article
id doaj.art-0f22fd2ee9da456ebbe6f2e3b767b291
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-04-14T01:48:22Z
publishDate 2015-10-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-0f22fd2ee9da456ebbe6f2e3b767b2912022-12-22T02:19:26ZengDove Medical PressInternational Journal of General Medicine1178-70742015-10-012015default33334424203Managing neurocysticercosis: challenges and solutionsFogang YFSavadogo AACamara MToffa DHBasse ASow ADNdiaye MMYannick Fogoum Fogang, Abdoul Aziz Savadogo, Massaman Camara, Dènahin Hinnoutondji Toffa, Anna Basse, Adjaratou Djeynabou Sow, Mouhamadou Mansour Ndiaye Neurology Department, Fann Teaching Hospital, Cheikh Anta Diop University, Dakar, Senegal Abstract: Taenia solium neurocysticercosis (NCC) is a major cause of neurological morbidity in the world. Variability in the neuropathology and clinical presentation of NCC often make it difficult to diagnose and manage. Diagnosis of NCC can be challenging especially in endemic and resource-limited countries where laboratory and imaging techniques are often lacking. NCC management can also be challenging as current treatment options are limited and involve symptomatic agents, antiparasitic agents, or surgery. Although antiparasitic treatment probably reduces the number of active lesions and long-term seizure frequency, its efficacy is limited and strategies to improve treatment regimens are warranted. Treatment decisions should be individualized in relation to the type of NCC. Initial measures should focus on symptomatic management, with antiparasitic therapy only to be considered later on, when appropriate. Symptomatic treatment remains the cornerstone in NCC management which should not only focuses on epilepsy, but also on other manifestations that cause considerable burden (recurrent headaches, cognitive decline). Accurate patients' categorization, better antiparasitic regimens, and definition of new clinical outcomes for trials on NCC could improve management quality and prognosis of NCC. Prevention strategies targeting tapeworm carriers and infected pigs are yielding good results in local models. If local elimination of transmission is confirmed and replicated, this will open the door to cysticercosis eradication efforts worldwide. Keywords: neurocysticercosis, Taenia solium, epilepsy, headache, albendazole, praziquantelhttps://www.dovepress.com/managing-neurocysticercosis-challenges-and-solutions-peer-reviewed-article-IJGM
spellingShingle Fogang YF
Savadogo AA
Camara M
Toffa DH
Basse A
Sow AD
Ndiaye MM
Managing neurocysticercosis: challenges and solutions
International Journal of General Medicine
title Managing neurocysticercosis: challenges and solutions
title_full Managing neurocysticercosis: challenges and solutions
title_fullStr Managing neurocysticercosis: challenges and solutions
title_full_unstemmed Managing neurocysticercosis: challenges and solutions
title_short Managing neurocysticercosis: challenges and solutions
title_sort managing neurocysticercosis challenges and solutions
url https://www.dovepress.com/managing-neurocysticercosis-challenges-and-solutions-peer-reviewed-article-IJGM
work_keys_str_mv AT fogangyf managingneurocysticercosischallengesandsolutions
AT savadogoaa managingneurocysticercosischallengesandsolutions
AT camaram managingneurocysticercosischallengesandsolutions
AT toffadh managingneurocysticercosischallengesandsolutions
AT bassea managingneurocysticercosischallengesandsolutions
AT sowad managingneurocysticercosischallengesandsolutions
AT ndiayemm managingneurocysticercosischallengesandsolutions